These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23279181)

  • 61. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
    Semkovska M; Bédard MA; Stip E
    Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A longer duration of schizophrenic illness has sex-specific associations within the working memory neural network in schizophrenia.
    Elsabagh S; Premkumar P; Anilkumar AP; Kumari V
    Behav Brain Res; 2009 Jul; 201(1):41-7. PubMed ID: 19428614
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Brain structural and functional dissociated patterns in schizophrenia.
    Zhuo C; Zhu J; Wang C; Qu H; Ma X; Tian H; Liu M; Qin W
    BMC Psychiatry; 2017 Jan; 17(1):45. PubMed ID: 28143464
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.
    Mata I; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; González-Blanch C; Ramírez-Bonilla M; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
    Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Correlates of patterns of substance abuse among patients with schizophrenia.
    Cuffel BJ; Heithoff KA; Lawson W
    Hosp Community Psychiatry; 1993 Mar; 44(3):247-51. PubMed ID: 8444435
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Neural Circuitry of Impaired Emotion Regulation in Substance Use Disorders.
    Wilcox CE; Pommy JM; Adinoff B
    Am J Psychiatry; 2016 Apr; 173(4):344-61. PubMed ID: 26771738
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Alcohol dependence and schizophrenia: what are the interrelationships?
    Soyka M
    Alcohol Alcohol Suppl; 1994; 2():473-8. PubMed ID: 8974370
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sex disparities in substance abuse research: Evaluating 23 years of structural neuroimaging studies.
    Lind KE; Gutierrez EJ; Yamamoto DJ; Regner MF; McKee SA; Tanabe J
    Drug Alcohol Depend; 2017 Apr; 173():92-98. PubMed ID: 28212516
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clearing the smoke: what do we know about adolescent cannabis use and schizophrenia?
    Hill MN
    J Psychiatry Neurosci; 2014 Mar; 39(2):75-7. PubMed ID: 24576402
    [No Abstract]   [Full Text] [Related]  

  • 70. Brain structure and function changes during the development of schizophrenia: the evidence from studies of subjects at increased genetic risk.
    Lawrie SM; McIntosh AM; Hall J; Owens DG; Johnstone EC
    Schizophr Bull; 2008 Mar; 34(2):330-40. PubMed ID: 18227083
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Neural Effects of Cognitive Training in Schizophrenia: A Systematic Review and Activation Likelihood Estimation Meta-analysis.
    Mothersill D; Donohoe G
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Aug; 4(8):688-696. PubMed ID: 31072761
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Common and separable neural alterations in substance use disorders: A coordinate-based meta-analyses of functional neuroimaging studies in humans.
    Klugah-Brown B; Di X; Zweerings J; Mathiak K; Becker B; Biswal B
    Hum Brain Mapp; 2020 Nov; 41(16):4459-4477. PubMed ID: 32964613
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Brain effects of cannabis--neuroimaging findings].
    Crippa JA; Lacerda AL; Amaro E; Busatto Filho G; Zuardi AW; Bressan RA
    Braz J Psychiatry; 2005 Mar; 27(1):70-8. PubMed ID: 15867988
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Psychoactive Substance Dependence: A Dentist's Challenge.
    Millar L
    Prim Dent J; 2015 May; 4(2):49-54. PubMed ID: 26556258
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Neuropathology of substance use disorders.
    Cadet JL; Bisagno V; Milroy CM
    Acta Neuropathol; 2014 Jan; 127(1):91-107. PubMed ID: 24292887
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The Limits between Schizophrenia and Bipolar Disorder: What Do Magnetic Resonance Findings Tell Us?
    Dobri ML; Diaz AP; Selvaraj S; Quevedo J; Walss-Bass C; Soares JC; Sanches M
    Behav Sci (Basel); 2022 Mar; 12(3):. PubMed ID: 35323397
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Neuroimaging schizophrenia: a picture is worth a thousand words, but is it saying anything important?
    Ahmed AO; Buckley PF; Hanna M
    Curr Psychiatry Rep; 2013 Mar; 15(3):345. PubMed ID: 23397252
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Neural substrates of substance use disorders.
    Paulus MP
    Curr Opin Neurol; 2022 Aug; 35(4):460-466. PubMed ID: 35856914
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The contribution of neuroimaging to understanding schizophrenia; past, present, and future.
    Sommer IE; Kahn RS
    Schizophr Bull; 2015 Jan; 41(1):1-3. PubMed ID: 25347988
    [No Abstract]   [Full Text] [Related]  

  • 80. Obstetric Complications and Brain Imaging in Schizophrenia: A Systematic Review.
    Costas-Carrera A; Garcia-Rizo C; Bitanihirwe B; Penadés R
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2020 Dec; 5(12):1077-1084. PubMed ID: 33012683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.